chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Developed nausea about 6 hrs after receiving Tdap vaccine which lasted for 2 hrs then developed chills for 2 hours then for the next 15 hours he had a mild fever, headache & body aches.
nausea; headache; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), HEADACHE (headache) and VOMITING (vomiting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NAUSEA (nausea), HEADACHE (headache) and VOMITING (vomiting). At the time of the report, NAUSEA (nausea), HEADACHE (headache) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.  Patient stated it's been 2 weeks since she was experiencing the events.
Infant with inconsolable crying starting about 1/2hr after shots given & continuing on & off for 3 hours & then continuous for another 3-4 hours. Infant WNL when seen in ER 6/19/12 655pm.
This spontaneous report as received from a registered nurse refers to a 15 month old patient of unknown gender. The patient's concurrent conditions, medical history and drug allergies were not reported. On 25-OCT-2016, the patient was vaccinated with an improperly stored dose of PEDVAXHIB (dose and route not reported) from lot # M020102, expiry date: 08-MAR-2019 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous temperature excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all follow up information has been received. Sender's Comments:  US-009507513-1610USA014705: US-009507513-1610USA014706: US-009507513-1610USA008140.
This spontaneous report as received from registered nurse refers to a female patient of unknown age who on 14-AUG-2013, was vaccinated twice with a 0.5 ml dose of GARDASIL intramuscularly (lot number not reported). No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.
Hidradenitis Suppurativa flareup; Hidradenitis Suppurativa flareup; This spontaneous case was reported by a consumer and describes the occurrence of HIDRADENITIS (Hidradenitis Suppurativa flareup) and CONDITION AGGRAVATED (Hidradenitis Suppurativa flareup) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Hidradenitis suppurativa.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. On an unknown date, the patient experienced HIDRADENITIS (Hidradenitis Suppurativa flareup) and CONDITION AGGRAVATED (Hidradenitis Suppurativa flareup). At the time of the report, HIDRADENITIS (Hidradenitis Suppurativa flareup) and CONDITION AGGRAVATED (Hidradenitis Suppurativa flareup) had resolved.            Concomitant medications were not reported.  It was unknown if patient was enrolled in COVID-19-Vaccine Trial. The reporter's causality for the event of Hidradenitis Suppurativa flareup with Adalimumab Solution for Injection was Not Provided.  Treatment medications were not reported.
deep cough that still persists +2 weeks but is improving; significant fatigue; upset stomach for about a week; booster; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Nov2021 11:00 (Batch/Lot number: unknown) at the age of 60 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "celiac disease" (unspecified if ongoing); "asthma" (unspecified if ongoing); "low thyroid: hypothyroidism" (unspecified if ongoing); "polycythemia" (unspecified if ongoing); "bradycardia" (unspecified if ongoing); "allergies to wheat, yeast, orange peel, high fructose corn syrup" (unspecified if ongoing); "allergy" (unspecified if ongoing), notes: material used in stress tests. Concomitant medication(s) included: BREO ELLIPTA; ALBUTEROL [SALBUTAMOL]; SYNTHROID; OMEPRAZOLE. Past drug history included: Morphine, reaction(s): "drug allergy"; Sensit, reaction(s): "drug allergy". Vaccination history included: Bnt162b2 (Dose 2, lot number: ER8737, Location of injection: Arm Right, Vaccine Administration Time: 11:15 AM), administration date: 29Mar2021, when the patient was 59 years old, for COVID-19 immunization; Bnt162b2 (Dose 1, lot number: EN6198, Location of injection: Arm Left, Vaccine Administration Time: 04:15 PM), administration date: 01Mar2021, when the patient was 59 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 26Nov2021 11:00, outcome "unknown", described as "booster"; COUGH (non-serious) with onset 26Nov2021 16:00, outcome "recovering", described as "deep cough that still persists +2 weeks but is improving"; FATIGUE (non-serious) with onset 26Nov2021 16:00, outcome "recovering", described as "significant fatigue"; ABDOMINAL DISCOMFORT (non-serious) with onset 26Nov2021 16:00, outcome "recovering", described as "upset stomach for about a week". Therapeutic measures were not taken as a result of cough, fatigue, abdominal discomfort.  Additional Information: Concomitant Therapy included more unspecified drugs. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Ringing (crickets) I hear in ears that I already had got louder (intensified) within a couple days of the vaccine. It?s constantly louder than before but at times has been extremely loud in right ear . Like birds chirping rather than Crickets.
At time of injection I became lightheaded and " spacey ". This lasted longer than 1 hour. Day 2. extremely sore  upper arm muscle, Day 5, Malaise and and tired  and no energy with lingering effects that are still present. Cannot sleep a full night, Muscles become sore and I must change position to relieve soreness, My balance has also been affected, Starting 6 weeks ago,  the bones in my thumbs and a few fingers click and cause pain at times,
Patient experienced redness down from injection site down towards elbow. Feels like muscle may be swelling. No pain.
Received the vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant) in a female patient of an unknown age (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20/2A) for COVID-19 vaccination.     Family history included Congestive heart failure (Family history- Mother (patient believes it to be genetic)). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) and PARACETAMOL (TYLENOL) for an unknown indication.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 03-Mar-2021. On 28-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant). On 28-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (Received the vaccine while pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Ultrasound and Glucose screening were done on 12 Jul 2020 (results not reported). No Treatment medications were reported.  Live, full-term birth on 25 Mar 2021 and 01 Feb 2018.   Most recent FOLLOW-UP information incorporated above includes: On 29-Dec-2020: Contact information added
This non-serious spontaneous case, initially received from other non-health professional (consumer) via Merck on 24-Jul-2018, concerning a female patient of unspecified age. The patient's current condition included diabetes (since an unspecified date) and cholesterol (since last few years). The patient was allergic to doxycycline, metformin, oestrogen and REGLAN. The concomitant medications included ZETIA for cholesterol, glimepiride, SYNTHROID. On an unspecified date, the patient was administered influenza virus (dose, route of administration, anatomical location, batch number, expiry date, manufacturer and trade name: not reported). On an unspecified date, after vaccination, the patient developed allergy. At the time of this report, the outcome of the event was not reported.
Bursa of left elbow - 13 cc fluid removed on 4/24/2018. Cardiac rehab personnel suspected enlargement sac at elbow was from injection.
Complains of spasm at injection site, spasms started 8/29/2022, states the spasms are pretty constant.
a long-term nursing home  resident, who has been fully vaccinated against COVID-19 about 7 months ago,  comes to emergency room complaining of sudden onset of temp substernal chest pain  with no associated shortness of breath, cough, fever.  His workup in the ER  showed a normal CMP.  His CBC was within normal limits excepting a hemoglobin  of 8.8 with a baseline being around 11.2.  Patient denies any epistaxis,  hemoptysis, hematemesis, melena, hematochezia, hematuria, and his stool for  occult blood was indeed negative; however, his COVID-19 screen came back as  positive.  Chest x-ray was raising possibility of infection or malignancy, so  a CT angio of the chest was done which shows no PE, but shows bilateral  ground-glass opacity, especially in the upper lobes consistent with COVID-19.   There is some bilateral mucus plugging as well and some small complex left  loculated pleural fluid, empyema versus sequelae of old hemothorax.  An ABG  was ordered and then the hospitalist service was called for admission.  Please  note, the pulmonologist is also being called for further workup.  At this  point of time, it appears prudent to have the patient admitted as an  observation to our COVID-19 unit.  I am starting the patient on some vitamin  D, vitamin C, and Mucinex.  We will await his ABG results to see if he would  benefit for any Decadron or not.  Please note, the patient's temperature was  100.1 when he came in.  His influenza swab was negative.  Because of  possibility of empyema, I might start him on Zosyn at this point of time and  have Pulmonary see him in the morning with a possible consult to IR to see if  his loculated pleural effusion even needs to be drained or treated  empirically.small left complex loculated effusion with pleural thickening , empyema vs sequela of hemothorax was suggested on CT scan report 09/10/21. He had positive  COVID 19 on admission 09/10/21 ( apparently fully vaccinated 7 months ago) . He was started  on zosyn, I discharged him on augmentin . Patient was initially on room air , and then 2 L NC , but back to room air. I started decadron and Remdesivir when he was using oxygen , but now doing well on RA.  Both cardiology and pulmonary medicine were consulted by admitting physician. Patient was evaluated by pulmonary medicine in course of hospitalization with plan for outpatient follow up . Patient does not want any surgical procedures for left pleural effusion at this time , but ok for follow up appointment with pulmonary medicine. I corresponded with case management who arranged a referral to facility with Dr.     EKG and trop on admission  did not show acute changes suggestive of ACS . Cardiology recommended medical management , patient was started on Carvedilol , Amlodipine . He also has iron deficiency anemia and started on Ferous sulphate 325 mg BID upon discharge.
The Client stated that she was not immunocompromised. There was a note in her E-chart about her taking these medications but I did not see the note until after I had given her the shot. I called the Client and spoke to her and to her daughter who is more fluent in English. I referred her to her RA DR. I also called and left a message for her RA DR.
Febrile seizures. Seizures stopped after 3 minutes and administration of Diastat, Ativan, and Versed. Child rec'd immunizations at approx 8am on 7/15/03. At midnight on 7/16/03, he experienced a febrile seizure and was hospitalized overnight.
Fever, headache, nausea, chills, body aches lasted about 12 hours. Then fatigue for another 12 hours.
Headache, nausea, vomiting, fever (99 degrees), chills, site tenderness.
Initial report received from a health care provider on 27/Mar/2006. A five-year-old patient (gender not reported had received an intramuscular, right arm injection of Daptacel, lot number number C2405AA, on 22/Mar/2006. Two days later, the patient experienced "redness and swelling of the entire arm after vaccination". The patient had received four previous doses. At the time of this report the patient had recovered from the event. The reporter in this case is the same as for 2006-00694, 2006-00695, 2006-00696, 2006-00697, 2006-00698, 2006-00693, and 2006-00700.
On February 19, 2021, on my left arm I noticed a small, tiny bump like a curling iron burn. I went to work, and it started getting larger. I went to the doctor since it was little known prescribed me a steroid cream. It became larger I went back to the doctor and was advised to stop taking the steroid and prescribed me antibiotic diagnosed me with Shingles.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. Pertinent medical history or drug allergies/drug reactions were not reported. On 24-MAR-2015, the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) (dose, route, lot number and expiration date were not provided). Concomitant medication was not provided. No adverse effect was reported. No product quality complaint (PQC) was involved. This is one of nine reports from the same reporter. Additional information has been requested.
Case number PHEH2015US012012, is an initial spontaneous report from a medical assistant received on 22 Jun 2015. This report refers to a 17 years old male patient. Medical history and concomitant medications were not reported. He was vaccinated with BEXSERO (batch number: 146101A) at a dose of 0.5 ml intramuscularly on 15 Jun 2015. It was reported that the patient received BEXSERO that reached up to 49F for 4 hours on 10 Jun 2015. No adverse event was reported.
I went for a routine mammogram on 05/10/2021 and my doctor found a small spot in my right breast the size of a pea. She scheduled an ultrasound and a biopsy was performed. The lab results came back showing an ILC and I am scheduled to have surgery on 08/27/2021.
swelling & vesicular formation in lt deltoid in inject site, seen by MD on 16DEC92 & 21DEC92; vesicles had cleared & some mild induration persisted conservative, symptomatic treatment only;
joint pain; burnt sensation on the tongue; throat sensitivity; bad taste in the mouth; muscle pain; joint pain (in hips, wrist, and elbow); joint pain (in hips, wrist, and elbow); fever; chills; achy; did not feel well; problems with energy level; fatigue; This is a spontaneous report from a contactable Nurse (patient herself).   A 40-year-old female received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number- EL9264, Expiry Date-UNKNOWN) via an unspecified route of administration on 02 Feb2021 (a 40-year-old) as dose 2, single for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, LOT Number- EL3249), dose 1, on 12Jan2021 for covid-19 immunization. On an unspecified date, patient experienced some symptoms, burnt sensation on the tongue, throat sensitivity, bad taste in the mouth, muscle pain, joint pain (in hips, wrist, and elbow) fever, chills lasted about 24 hours but again a week later she experienced achy, fever, did not feel well, bad taste and joint pain. she said she had a friend who had some symptoms and her friend said other people had experienced symptoms also. Reporter stated, "I had the Covid vaccine, chills you know I had lot of symptoms that I reported to the number they gave me to report to but I noticed that about like after 7 days later I was having some chills again and the muscle ache and joint pain and I thought maybe it was not related, I mean I do not think about related to that I just know having a lot of problems with energy level, fatigue and then those issues and it was kind of dissipated a little bit but I am still having the joint and muscle aches I noticed that about like and then it is also weird burnt like sensation and taste in my mouth and it never burnt my mouth and it has not gone away. It has been persistent for probably about a week and a half now or 10 days and I did not know was that anything you had heard of or not, but I know that I have friends in the medical field who are saying they have heard some lot of stories of people after they take their vaccine. Reporter stated, I am not. On the first one I was taking Celebrex (Treatment), the first vaccine and I stopped that shortly after that that is why I stopped it on the 21Jan. Reporter stated, It was treatment for like a joint issue. Reporter stated, I took 1 Ibuprofen when I needed it. Reporter stated, I do not know. I think it went right after because I was within 72 hours I think after 24 hours right after the second one that I had and then it went away and came back like I said. The therapeutic measure was taken with all events. The outcome of all the events were unknown.  No follow up attempts are possible. No further information is expected.
8-20-08 - Late morning - redness, swollen, warm to the touch noted by parent.  8-21-08 early morning - increased redness, swollen, blisters.  Referred to ER for evaluation, recommended by ER for cool compress, ibuprofen.
Expired product administered; No further information provided. No adverse event occurred; This spontaneous report as received from a consumer referring to a patient of unknown age and gender. The patient's medical history, historical drugs, allergies, concurrent conditions and concomitant therapies were not provided.  On an unknown date the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot number, expiry date, dose, anatomical location, route of administration and dose description was not reported) for prophylaxis (expired product administered). Reporter stated measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) was about 4 month expired but did not have lot number and expiration date and product did not have nay temperature excursions prior to administration. No further information provided. No adverse event occurred (no adverse event).
Swelling of hands/feet/eyes and hives began within 3 hours, post vax, and continued off and on, several times per day with increasing severity for 5 days. Day 5, began vomiting X 3 throughout the day along with hives and swelling. Day 6, all symptoms gone. Treated with Benadryl. (Hives and welts all over body).
Some symptoms I have been having from the vaccine; A spontaneous report was received from a consumer concerning (herself) of an unknown age, female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced some symptoms I have been having from the vaccine (Adverse event).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received her first of two planned doses of mRNA-1273 (Lot number: Unknown) via unknown route for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced the some symptoms I have been having from the vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome of event, some symptoms I have been having from the vaccine was unknown..; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
Anaphylactic shock - throat restricting, tongue swelling, racing heart, rash predominantly on chest and neck. PB was elevated, dizzy, weak. Symptoms escalated quickly. Immediately flagged help from nearby medic.
Dose 2 has not been administered as of yet; patient received the first dose of rotarix 26 weeks and 1 day ago; This non-serious case was reported by a physician via call center representative and described the occurrence of inappropriate age at vaccine administration in a neonate male patient who received Rota (Rotarix lyophilized formulation) for prophylaxis.   Co-suspect products included Rota (Rotarix lyophilized formulation) for prophylaxis.   In MAR-2023, the patient received the 1st dose of Rotarix lyophilized formulation. On an unknown date, the patient did not receive the 2nd dose of Rotarix lyophilized formulation. In MAR-2023, an unknown time after receiving Rotarix lyophilized formulation and not applicable after receiving Rotarix lyophilized formulation, the patient experienced inappropriate age at vaccine administration (Verbatim: patient received the first dose of rotarix 26 weeks and 1 day ago). On an unknown date, the patient experienced incomplete course of vaccination (Verbatim: Dose 2 has not been administered as of yet).  The outcome of the inappropriate age at vaccine administration and incomplete course of vaccination were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 20-SEP-2023 The patient received the 1st dose of Rotarix before recommended age, which led to inappropriate age at vaccine administration and till the time of reporting the patient did not receive the 2nd dose of Rotarix, which led to incomplete course of vaccination. The reporter did not consent to follow-up. No additional information provided.
This spontaneous report as received from a pharmacist via company representative refers to an unknown patient of unknown age and unknown gender. Medical history and current conditions were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, strength, route, lot number, expiration date and anatomical location were unspecified). No concomitant therapies were reported. On an unknown date the patient developed a chickenpox-like rash after having ZOSTAVAX. The outcome of the event was unknown. This is one of several reports received from the same reporter. Additional information is not expected.